Mendelian randomization–inspired targeted polyphenol nanoplatform for synergistic osteoarthritis therapy
Qin Ouyang, Linyu Su, Sisi Li, Runwei Gao, Feixiang Ding, Huaiyu Jian, Zhaoqian Liu, Jianjun Zhou 等 13 位
Central South University First Affiliated Hospital of University of South China University of South China Xiangnan University
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Osteoarthritis (OA) is a debilitating joint disorder with few disease-modifying treatments. Inspired by a Mendelian randomization analysis of over 470,000 individuals that identified a causal association between green tea consumption and a reduced risk of OA, this study developed a multifunctional nanomedicine (Dex@TPNs-FA, denoted as DTF) by encapsulating dexamethasone (Dex) in self-assembled tea polyphenol nanoparticles (TPNs) modified with folic acid for targeted delivery to synovial macrophages. DTF reduced inflammation and oxidative stress, inhibited apoptosis, and promoted cartilage matrix synthesis in LPS-stimulated macrophages and IL-1 β -damaged chondrocytes. Transcriptomic analysis revealed that DTF upregulated HIF1 α and suppressed TNF and IL17 signaling pathways. In both MIA-induced acute and DMM-induced chronic OA models, DTF alleviated pain, reduced synovitis, and preserved cartilage integrity without systemic toxicity. This study presents a genetics-guided nanotherapeutic approach, highlighting a translational pathway from population-based evidence to targeted OA treatment. This study reported a genetics-inspired strategy for osteoarthritis: a targeted nanoparticle delivers a combined therapy to reduce joint inflammation and promote cartilage regeneration.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Osteoarthritis Treatment and Mechanisms
Nanoparticle-Based Drug Delivery · Natural Compounds in Disease Treatment